Calendar

Here we publish regional, national and international activities in the life science sector.

2025
november03-november05

BIO-Europe 2025

Vienna, Austria
Member discount
Read moreExternal event
november10

MVA Annual Summit 2025

Clarion Hotel Copenhagen Airport, Ellehammersvej 20, 2770 Kastrup, Denmark
Member discount
Read moreExternal event
november12

Healthcare Meetup

Lobbybaren Twentyfourseven, Gothia Towers, Gothenburg
Read moreSwedenBio event
november17

Investival Showcase Europe 2025

Old Billingsgate, London, UK
Member discount
Read moreExternal event
november25-november26

Conference Focus Clinical Trials

Uppsala konsert och kongress (UKK), Digital via Teams
Read moreExternal event
december01

Hesa-Fredrik AW på Haymarket

Lobbybaren, hotell Haymarket, Hötorget, Stockholm
Read moreSwedenBio event
2026
januari12-januari14

Biotech Showcase 2026

San Francisco, CA
Member discount
Read moreExternal event
januari21

SwedenBIO Summit 2025

Grand Hôtel, Södra Blasieholmshamnen 8, Stockholm
Read moreSwedenBio event
mars04-mars05

19th Annual European Life Sciences CEO Forum

Hilton Zurich Airport Hotel, Switzerland States

Business & Finance

How to create sustainable trading on the stock exchange

The life science sector is one of the strongest for listed small companies in Sweden. At the same time, the competition in the sector is fierce and it is necessary to work with the issues that affect share trading. A well-functioning share trading is important for creating growth in small and medium-sized companies.

Offer to you as an incubator company

Life for startup companies was not without challenges before the effects of the corona crisis hit, and the situation is now tough for many smaller companies. Now we want to contribute to building Sweden’s next generation of life science companies strong, for future export revenue and innovation power. Startup companies with up to four employees must be members of SwedenBIO for an annual fee of SEK 1,000.

What does the future look like for dual listings in the US? When is the right time? These are questions Adam Kostyal devotes himself to answering in the latest episode of Brännpunkt Life Science.

Brännpunkt Life Science is an interview series in collaboration with DNB Sweden that focuses the magnifying glass on the intersection between innovation, capital and health. In the first part, we meet Adam Kostyal, European head of listing at Nasdaq, who looks at how the stock market year looked for the sector, talks about the impact of the pandemic and shares his predictions for the future.